SONA Asset Management (US)’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.03M Hold
500,000
0.11% 119
2026
Q1
$4.99M Buy
500,000
+200,000
+67% +$1.99M 0.11% 91
2025
Q4
$2.97M Buy
+300,000
New +$2.97M 0.07% 103

Other funds holding DMII

SONA Asset Management (US)'s DMII Position: Q2 2026 in Review

SONA Asset Management (US) held its Drugs Made In America Acquisition II Corp (DMII) position steady in Q2 2026 at 500,000 shares worth $5.03M. The position accounts for 0.11% of the portfolio, ranked #119.

SONA Asset Management (US) first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • SONA Asset Management (US) held 500,000 shares of Drugs Made In America Acquisition II Corp worth $5.03M as of Q2 2026.
  • SONA Asset Management (US) left its Drugs Made In America Acquisition II Corp share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp made up 0.11% of SONA Asset Management (US)'s portfolio in Q2 2026, its #119 holding.
  • SONA Asset Management (US) first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on SONA Asset Management (US)'s 13F filing for Q2 2026, filed 14 Aug 2026.